financetom
Business
financetom
/
Business
/
Update: E3 Lithium Rises 10% as it Nears Final Commissioning of Clearwater Demonstration Facility Phase 1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: E3 Lithium Rises 10% as it Nears Final Commissioning of Clearwater Demonstration Facility Phase 1
Aug 12, 2025 9:22 AM

11:58 AM EDT, 08/12/2025 (MT Newswires) -- E3 Lithium ( EEMMF ) on Tuesday said it is progressing toward final inspection and commissioning of Phase 1 of its Clearwater project demonstration facility.

The goal of Phase 1 is to fully operationalize the direct lithium extraction system from brines and associated polishing and purification units to produce a high-quality lithium chloride, which will support the production of battery-grade lithium carbonate.

All major equipment has arrived on site and the DLE system and associated polishing and purification units are now fully assembled.

The company expects to complete the assembly of the remaining equipment within the next week.

Assuming no major issues are identified through the operational review, commissioning is scheduled by the end of August, commencing with the introduction of brine.

E3 Lithium ( EEMMF ) shares were last seen up $0.14 to $1.55 on the TSX Venture Exchange.

Price: 1.53, Change: +0.12, Percent Change: +8.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IO Biotech Gets Data Monitoring Committee Recommendation to Continue Phase 3 Melanoma Study
IO Biotech Gets Data Monitoring Committee Recommendation to Continue Phase 3 Melanoma Study
Sep 1, 2024
04:34 PM EDT, 08/30/2024 (MT Newswires) -- IO Biotech ( IOBT ) said Friday that an Independent Data Monitoring Committee has recommended the continuation of its late-stage trial of vaccine candidate IO102-IO103 in combination with Merck's ( MRK ) Keytruda as a first-line treatment for patients with unresectable or metastatic melanoma. No new safety signals were observed at interim analysis,...
Eaton Corp Insider Sold Shares Worth $950,584, According to a Recent SEC Filing
Eaton Corp Insider Sold Shares Worth $950,584, According to a Recent SEC Filing
Sep 1, 2024
04:37 PM EDT, 08/30/2024 (MT Newswires) -- Michael Yelton, President, Americas Region, Electrical Sector of Eaton Corporation ( ETN ), on August 29, 2024, sold 3,136 shares in Eaton Corp ( ETN ) for $950,584. Following the Form 4 filing with the SEC, Yelton has control over a total of 8,217 shares of the company, with 3,914 shares held directly...
Rakovina Therapeutics Second-Quarter Loss Widens on Higher Spending
Rakovina Therapeutics Second-Quarter Loss Widens on Higher Spending
Sep 1, 2024
04:35 PM EDT, 08/30/2024 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) on Friday said its second-quarter loss widened on higher costs, including a boost to research and development spending. The biopharmaceutical company said it lost $0.82 million, or $0.01 per share, in the period, compared to a loss of $0.6 million, 0r $0.01, in the year prior quarter. The...
Ardmore Shipping Files $500 Million Mixed Shelf
Ardmore Shipping Files $500 Million Mixed Shelf
Sep 1, 2024
04:54 PM EDT, 08/30/2024 (MT Newswires) -- Ardmore Shipping ( ASC ) late Friday filed a registration statement for up to $500 million of several securities. The company may offer and sell securities, including common and preferred stock, debt securities, convertible debt securities, warrants, and units, from time to time in one or more offerings. The company said net proceeds...
Copyright 2023-2026 - www.financetom.com All Rights Reserved